Dietary carnosic acid suppresses hepatic steatosis formation via regulation of hepatic fatty acid metabolism in high-fat diet-fed mice
- Authors
- Park, Mi-Young; Mun, Seong Taek
- Issue Date
- Aug-2013
- Publisher
- 한국영양학회
- Keywords
- Carnosic acid; high-fat diet; hepatic steatosis; lipogenesis; fatty acid oxidation
- Citation
- Nutrition Research and Practice, v.7, no.4, pp 294 - 301
- Pages
- 8
- Journal Title
- Nutrition Research and Practice
- Volume
- 7
- Number
- 4
- Start Page
- 294
- End Page
- 301
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13491
- DOI
- 10.4162/nrp.2013.7.4.294
- ISSN
- 1976-1457
2005-6168
- Abstract
- In this study, we examined the hepatic anti-steatosis activity of carnosic acid (CA), a phenolic compound of rosemary (Rosmarinus officinalis) leaves, as well as its possible mechanism of action, in a high-fat diet (HFD)-fed mice model. Mice were fed a HFD, or a HFD supplemented with 0.01% (w/w) CA or 0.02% (w/w) CA, for a period of 12 weeks, after which changes in body weight, blood lipid profiles, and fatty acid mechanism markers were evaluated. The 0.02% (w/w) CA diet resulted in a marked decline in steatosis grade, as well as in homeostasis model assessment of. insulin resistance (HOMA-IR) index values, intraperitoneal glucose tolerance test (IGTT) results, body weight gain, liver weight, and blood lipid levels (P < 0.05), The expression level of hepatic lipogenic genes, such as sterol regulating element binding protein-1c (SREBP-1c), liver-fatty acid binding protein (L-FABP), stearoyl-CoA desaturase 1 (SCD1), and fatty acid synthase (FAS), was significantly lower in mice fed 0.01% (w/w) CA and 0.02% (w/w) CA diets than that in the HFD group; on the other hand, the expression level of beta-oxidation-related genes, such as peroxisome proliferator-activated receptor alpha (PPAR-alpha), carnitine palmitoyltransferase 1 (CPT-1), and acyl-CoA oxidase (ACO), was higher in mice fed a 0.02% (w/w) CA diet, than that in the HFD group (P < 0.05). In addition, the hepatic content of palmitic acid (C16:0), palmitoleic acid (C16:1), and oleic acid (C18:1) was significantly lower in mice fed the 0.02% (w/w) CA diet than that in the HFD group (P < 0.05). These results suggest that orally administered CA suppressed HFD-induced hepatic steatosis and fatty liver-related metabolic disorders through decrease of de novo lipogenesis and fatty acid elongation and increase of fatty acid beta-oxidation in mice.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Obstetrics and Gynecology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13491)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.